Mice that are deficient in hepatic FOXO3 are more susceptible to non-alcoholic steatohepatitis than WT controls (Pan et al., 2017), which provided strong evidence for FOXO3 protecting against the diet-induced fatty liver disease. Here, FOXO3 is linked to metabolic dysfunction-associated steatohepatitis.